Beam Therapeutics (BEAM) Fair Value & DCF
BEAM$22.83-1.20 -4.99%
Market cap$2.36BEnterprise value$2.90BRevenue (TTM)$146.64MMarket position—
Score
68
Bullish
Value
58
Quality
45
Growth
100
Beam Therapeutics Inc. (BEAM) trades at $22.83 on $2.36B of equity value, with a trailing P/E of -27.79. Fair value on Stocklytics blends discounted cash flow and an earnings-based cross-check when the saved model is on file. The price and ratio here are from the live quote.